5-Lipoxygenase activation may facilitate an interleukin-1 transduction signal.
Mugridge
K G
KG
Sclavo Research Centre, Laboratory of Pharmacology, Siena, Italy.
Perretti
M
M
Parente
L
L
D000311:Adrenal Glands / Q000502:physiology; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000187:drug effects*; D002867:Chromones / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D005753:Gastric Mucosa / Q000378:metabolism; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000494:pharmacology*; D015289:Leukotrienes / Q000096:biosynthesis; D009637:Masoprocol / Q000494:pharmacology; D010452:Peptide Biosynthesis; D011453:Prostaglandins / Q000096:biosynthesis; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology; D013189:SRS-A / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects*
D002867:Chromones; D007375:Interleukin-1; D015289:Leukotrienes; D011453:Prostaglandins; D011994:Recombinant Proteins; D013189:SRS-A; D009637:Masoprocol; C006312:FPL 55712; D001094:Arachidonate 5-Lipoxygenase